Therapeutic target biomarkers of patient-derived xenograft models of gastric-type cervical adenocarcinoma

• Príomhchruthaitheoirí: Yuki Kojima (Údar), Hiroshi Yoshida (Údar), Toshihiro Okuya (Údar), Hitomi S Okuma (Údar), Tadaaki Nishikawa (Údar), Maki Tanioka (Údar), Kazuki Sudo (Údar), Emi Noguchi (Údar), Tatsunori Shimoi (Údar), Kenji Tamura (Údar), Yasuhito Tanase (Údar), Masaya Uno (Údar), Mitsuya Ishikawa (Údar), Motoko Arakaki (Údar), Hitoshi Ichikawa (Údar), Shigehiro Yagishita (Údar), Akinobu Hamada (Údar), Yasuhiro Fujiwara (Údar), Kan Yonemori (Údar), Tomoyasu Kato (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Elsevier, 2023-12-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Background: Most cervical adenocarcinomas are associated with human papillomavirus (HPV). Gastric-type cervical adenocarcinoma (GAS), an HPV-independent adenocarcinoma, shows an aggressive clinical feature, resulting in a poor prognosis. Resistance to chemotherapy poses a difficulty in managing pati...